(Q40781642)

23 September 2017

1 reference

title

Innovative designs of controlled clinical trials in epilepsy (English)

1 reference

23 September 2017

Gram L

1

1 reference

23 September 2017

Schmidt D

series ordinal

2

1 reference

23 September 2017

publication date

1 January 1993

1 reference

23 September 2017

1 reference

23 September 2017

volume

34 Suppl 7

1 reference

23 September 2017

page(s)

S1-6

1 reference

Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB04589.X

Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB04589.X

Regression Towards Mediocrity in Hereditary Stature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB04589.X

The two-period cross-over clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB04589.X

Felbamate for partial seizures: results of a controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB04589.X

Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB04589.X

Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1993.TB04589.X

10.1111/J.1528-1157.1993.TB04589.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference